Literature DB >> 21361786

Origin of exhaled breath particles from healthy and human rhinovirus-infected subjects.

Patricia Fabian1, Joseph Brain, E Andres Houseman, James Gern, Donald K Milton.   

Abstract

BACKGROUND: Exhaled breath studies suggest that humans exhale fine particles during tidal breathing, but little is known of their physical origin in the respiratory system during health or disease.
METHODS: Particles generated by 3 healthy and 16 human rhinovirus (HRV)-infected subjects were counted using an optical particle counter with nominal diameter-size bins ranging between 0.3 and 10 μm. Data were collected from HRV-infected subjects during tidal breathing. In addition, data from healthy subjects were collected during coughs, swallows, tidal breathing, and breathing to total lung capacity (TLC) and residual volume (RV). Using general additive models, we graphed exhaled particle concentration versus airflow during exhalation. Exhaled particles were collected from expired air on gelatin filters and analyzed for HRV via quantitative PCR.
RESULTS: HRV-infected subjects exhaled from 0.1 to 7200 particles per liter of exhaled air during tidal breathing (geometric mean = 32 part/L). A small fraction (24%) of subjects exhaled most (81%) of the particles measured and 82% of particles detected were 0.300-0.499 μm. Minute ventilation, maximum airflow during exhalation, and forced expiratory volume 1 second (FEV(1) % predicted) were positively correlated with particle production. No human rhinovirus was detected in exhaled breath samples. Three healthy subjects exhaled less than 100 particles per liter of exhaled air during tidal breathing and increased particle concentrations more with exhalation to RV than with coughing, swallowing, or rapid exhalation.
CONCLUSIONS: Submicron particles were detected in the exhaled breath of healthy and HRV-infected subjects. Particle concentrations were correlated with airflow during the first half of exhalation, and peaked at the end of exhalation, indicating both lower and upper airways as particle sources. The effect of breathing maneuver suggested a major contribution from lower airways, probably the result of opening collapsed small airways and alveoli.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21361786      PMCID: PMC3123971          DOI: 10.1089/jamp.2010.0815

Source DB:  PubMed          Journal:  J Aerosol Med Pulm Drug Deliv        ISSN: 1941-2711            Impact factor:   2.849


  28 in total

1.  Relationship between exhaled breath condensate volume and measurements of lung volumes.

Authors:  Jia Liu; Paul S Thomas
Journal:  Respiration       Date:  2006-06-26       Impact factor: 3.580

2.  The mechanism of breath aerosol formation.

Authors:  Graham Richard Johnson; Lidia Morawska
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2009-09       Impact factor: 2.849

3.  Inhaling to mitigate exhaled bioaerosols.

Authors:  David A Edwards; Jonathan C Man; Peter Brand; Jeffrey P Katstra; K Sommerer; Howard A Stone; Edward Nardell; Gerhard Scheuch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

4.  An optimized method to detect influenza virus and human rhinovirus from exhaled breath and the airborne environment.

Authors:  Patricia Fabian; James Joseph McDevitt; Wai-Ming Lee; Eugene Andres Houseman; Donald Kirby Milton
Journal:  J Environ Monit       Date:  2008-12-01

5.  Increased macrophage-derived chemokine in exhaled breath condensate and plasma from children with asthma.

Authors:  T F Leung; G W K Wong; F W S Ko; C W K Lam; T F Fok
Journal:  Clin Exp Allergy       Date:  2004-05       Impact factor: 5.018

Review 6.  Rhinoviruses: important respiratory pathogens.

Authors:  A Pitkäranta; F G Hayden
Journal:  Ann Med       Date:  1998-12       Impact factor: 4.709

7.  Airborne influenza virus detection with four aerosol samplers using molecular and infectivity assays: considerations for a new infectious virus aerosol sampler.

Authors:  P Fabian; J J McDevitt; E A Houseman; D K Milton
Journal:  Indoor Air       Date:  2009-05-26       Impact factor: 5.770

8.  The numbers and the sites of origin of the droplets expelled during expiratory activities.

Authors:  J P DUGUID
Journal:  Edinb Med J       Date:  1945-11

9.  Interleukin-6 is increased in breath condensate of patients with non-small cell lung cancer.

Authors:  G E Carpagnano; O Resta; M P Foschino-Barbaro; E Gramiccioni; F Carpagnano
Journal:  Int J Biol Markers       Date:  2002 Apr-Jun       Impact factor: 3.248

10.  THE SIZE OF INFLUENZA VIRUS.

Authors:  W M Stanley
Journal:  J Exp Med       Date:  1944-03-01       Impact factor: 14.307

View more
  53 in total

1.  Characterizations of particle size distribution of the droplets exhaled by sneeze.

Authors:  Z Y Han; W G Weng; Q Y Huang
Journal:  J R Soc Interface       Date:  2013-09-11       Impact factor: 4.118

Review 2.  Coronavirus Infection Prevention by Wearing Masks.

Authors:  Thi Sinh Vo; Tran Thi Thu Ngoc Vo; Tran Thi Bich Chau Vo
Journal:  Eurasian J Med       Date:  2020-06

3.  Metabolomic Evaluation of Neutrophilic Airway Inflammation in Cystic Fibrosis.

Authors:  Charles R Esther; Raymond D Coakley; Ashley G Henderson; Yi-Hui Zhou; Fred A Wright; Richard C Boucher
Journal:  Chest       Date:  2015-08       Impact factor: 9.410

4.  SARS-CoV-2 inactivation by ultraviolet radiation and visible light is dependent on wavelength and sample matrix.

Authors:  Michael A Schuit; Thomas C Larason; Melissa L Krause; Brian M Green; Brian P Holland; Stewart P Wood; Steven Grantham; Yuqin Zong; Clarence J Zarobila; Denise L Freeburger; David M Miller; Jordan K Bohannon; Shanna A Ratnesar-Shumate; Ernest R Blatchley; Xing Li; Paul A Dabisch; C Cameron Miller
Journal:  J Photochem Photobiol B       Date:  2022-06-23       Impact factor: 6.814

5.  Droplet aerosols transportation and deposition for three respiratory behaviors in a typical negative pressure isolation ward.

Authors:  Yongxin Wang; Zhijian Liu; Haiyang Liu; Minnan Wu; Junzhou He; Guoqing Cao
Journal:  Build Environ       Date:  2022-05-30       Impact factor: 7.093

6.  Modeling aerosol transmission of SARS-CoV-2 from human-exhaled particles in a hospital ward.

Authors:  Lip Huat Saw; Bey Fen Leo; Norefrina Shafinaz Md Nor; Chee Wai Yip; Nazlina Ibrahim; Haris Hafizal Abd Hamid; Mohd Talib Latif; Chin Yik Lin; Mohd Shahrul Mohd Nadzir
Journal:  Environ Sci Pollut Res Int       Date:  2021-05-25       Impact factor: 4.223

7.  Influenza aerosols in UK hospitals during the H1N1 (2009) pandemic--the risk of aerosol generation during medical procedures.

Authors:  Katy-Anne Thompson; John V Pappachan; Allan M Bennett; Himanshu Mittal; Susan Macken; Brian K Dove; Jonathan S Nguyen-Van-Tam; Vicky R Copley; Sarah O'Brien; Peter Hoffman; Simon Parks; Andrew Bentley; Barbara Isalska; Gail Thomson
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

8.  Collection of aerosolized human cytokines using Teflon® filters.

Authors:  Jennifer H McKenzie; James J McDevitt; M Patricia Fabian; Grace M Hwang; Donald K Milton
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

9.  Investigating the relationship between breath aerosol size and exhaled breath condensate (EBC) metabolomic content.

Authors:  Alexander J Schmidt; Eva Borras; Nicholas J Kenyon; Cristina E Davis
Journal:  J Breath Res       Date:  2020-10-06       Impact factor: 3.262

10.  The SARS-CoV-2 viral load in COVID-19 patients is lower on face mask filters than on nasopharyngeal swabs.

Authors:  Agnieszka Smolinska; David S Jessop; Kirk L Pappan; Alexandra De Saedeleer; Amerjit Kang; Alexandra L Martin; Max Allsworth; Charlotte Tyson; Martine P Bos; Matt Clancy; Mike Morel; Tony Cooke; Tom Dymond; Claire Harris; Jacqui Galloway; Paul Bresser; Nynke Dijkstra; Viresh Jagesar; Paul H M Savelkoul; Erik V H Beuken; Wesley H V Nix; Renaud Louis; Muriel Delvaux; Doriane Calmes; Benoit Ernst; Simona Pollini; Anna Peired; Julien Guiot; Sara Tomassetti; Andries E Budding; Frank McCaughan; Stefan J Marciniak; Marc P van der Schee
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.